Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Eculizumab treatment alters the proteometabolome beyond the inhibition of complement.

  • Authors : Nelke C; Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.; Schroeter CB

Subjects: Complement C5* ; Myasthenia Gravis*/Myasthenia Gravis*/Myasthenia Gravis*/drug therapy; Humans

  • Source: JCI insight [JCI Insight] 2023 Jul 10; Vol. 8 (13). Date of Electronic Publication: 2023 Jul 10.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model:

Record details

×
Academic Journal

Complement and coagulation: key triggers of COVID-19-induced multiorgan pathology.

Subjects: *COVID-19; *ECULIZUMAB; *PATHOLOGY

  • Source: Journal of Clinical Investigation. Nov2020, Vol. 130 Issue 11, p5674-5676. 3p. 1 Diagram.

Record details

×
Academic Journal

Microglia complement astrocytes in neuromyelitis optica

  • Source: Journal of Clinical Investigation. August, 2020, Vol. 130 Issue 8, p3961, 4 p.

Record details

×
Academic Journal

COVID-19, microangiopathy, hemostatic activation, and complement

  • Source: Journal of Clinical Investigation. August, 2020, Vol. 130 Issue 8, p3950, 4 p.

Record details

×
Academic Journal

Complementopathies and precision medicine

  • Source: Journal of Clinical Investigation. May, 2020, Vol. 130 Issue 5, p2152, 12 p.

Record details

×
  • 1-10 of  115 results for ""ECULIZUMAB""